TD-8954
0095
Phase 1 small_molecule terminated
Quick answer
TD-8954 for Gastrointestinal Motility Disorder is a Phase 1 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Gastrointestinal Motility Disorder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated